283 related articles for article (PubMed ID: 18760289)
1. Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.
Placzek EA; Okamoto Y; Ueda N; Barker EL
Neuropharmacology; 2008 Dec; 55(7):1095-104. PubMed ID: 18760289
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids: synthesis and degradation.
Di Marzo V
Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
[TBL] [Abstract][Full Text] [Related]
3. Organized trafficking of anandamide and related lipids.
Yates ML; Barker EL
Vitam Horm; 2009; 81():25-53. PubMed ID: 19647107
[TBL] [Abstract][Full Text] [Related]
4. Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells.
Bari M; Spagnuolo P; Fezza F; Oddi S; Pasquariello N; Finazzi-Agrò A; Maccarrone M
J Immunol; 2006 Oct; 177(8):4971-80. PubMed ID: 17015679
[TBL] [Abstract][Full Text] [Related]
5. New insights into endocannabinoid degradation and its therapeutic potential.
Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
[TBL] [Abstract][Full Text] [Related]
6. Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells.
Bardell TK; Barker EL
Neurochem Int; 2010 Aug; 57(1):76-83. PubMed ID: 20466028
[TBL] [Abstract][Full Text] [Related]
7. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoid biosynthesis and inactivation, from simple to complex.
Muccioli GG
Drug Discov Today; 2010 Jun; 15(11-12):474-83. PubMed ID: 20304091
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
Ueda N; Tsuboi K; Uyama T; Ohnishi T
Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
[TBL] [Abstract][Full Text] [Related]
11. Endogenous cannabinoids: structure and metabolism.
Bisogno T
J Neuroendocrinol; 2008 May; 20 Suppl 1():1-9. PubMed ID: 18426492
[TBL] [Abstract][Full Text] [Related]
12. Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line.
Rimmerman N; Hughes HV; Bradshaw HB; Pazos MX; Mackie K; Prieto AL; Walker JM
Br J Pharmacol; 2008 Jan; 153(2):380-9. PubMed ID: 17965731
[TBL] [Abstract][Full Text] [Related]
13. Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids.
Thors L; Fowler CJ
Eur J Pharmacol; 2009 Oct; 621(1-3):10-8. PubMed ID: 19715690
[TBL] [Abstract][Full Text] [Related]
14. Critical enzymes involved in endocannabinoid metabolism.
Basavarajappa BS
Protein Pept Lett; 2007; 14(3):237-46. PubMed ID: 17346227
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid metabolic pathways and enzymes.
Ligresti A; Cascio MG; Di Marzo V
Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679
[TBL] [Abstract][Full Text] [Related]
16. Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide.
McFarland MJ; Terebova EA; Barker EL
AAPS J; 2006 Mar; 8(1):E95-100. PubMed ID: 16584138
[TBL] [Abstract][Full Text] [Related]
17. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
[TBL] [Abstract][Full Text] [Related]
18. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.
Bisogno T; Berrendero F; Ambrosino G; Cebeira M; Ramos JA; Fernandez-Ruiz JJ; Di Marzo V
Biochem Biophys Res Commun; 1999 Mar; 256(2):377-80. PubMed ID: 10079192
[TBL] [Abstract][Full Text] [Related]
19. Natural and synthetic endocannabinoids and their structure-activity relationships.
Palmer SL; Khanolkar AD; Makriyannis A
Curr Pharm Des; 2000 Sep; 6(13):1381-97. PubMed ID: 10903399
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
